- Scheme Category:
- Equity Scheme >
NAV: ₹ ↓ -0.36%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth and its peers as on 1 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth | 21.19% | -0.36% | -3.45% | -2.53% | 3.85% | 22.13% | - | - | - | - |
| Nippon India Banking & Financial Services Fund - Direct Plan Growth Plan - Growth Option | -7.69% | -0.2% | -2.36% | -5.58% | -6.86% | -1.79% | 10.2% | 12.12% | 13.77% | 12.61% |
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | 10.34% | -0.29% | -2.87% | -2.96% | 0.79% | 12.36% | 17.62% | 13.51% | 23.05% | 15.49% |
| Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option | 5.09% | -1.35% | -3.26% | -4.54% | -5.29% | 6.07% | 16.98% | 19.46% | 22.25% | 17.59% |
| DSP Healthcare Fund - Direct Plan - Growth | 14.38% | -0.41% | -3.06% | -3.45% | 3.21% | 15.61% | 20.7% | 15.23% | 25.89% | - |
| DSP Banking & Financial Services Fund - Direct - Growth | -1.5% | -0.91% | -2.39% | -7.87% | -6.3% | 5.81% | - | - | - | - |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | - | 1.44% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -2.53% | -5.38% | 6.26% | -3.75% | 6.65% | 4.99% | 7.17% | 4.23% | 3.14% | -2.18% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 14.41% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 93.64% | 2.52% (Arbitrage: 0.00%) | 0.00% | 0.00% | 3.84% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.45% | |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 7.40% | |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 6.78% | |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.73% | |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.78% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 3.32% | |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 3.25% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.05% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.88% | |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.66% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.58% | |
| Corona Remedies Limited | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 2.35% | |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 2.35% | |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 2.31% | |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.21% | |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 2.01% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 1.92% | |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 1.92% | |
| Narayana Hrudayalaya Limited | NH (INE410P01011) | Healthcare Services | 1.76% | |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.72% | |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.68% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 1.65% | |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 1.59% | |
| Navin Fluorine International Limited | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 1.53% | |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 1.44% | |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.27% | |
| Procter & Gamble Health Limited | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 1.25% | |
| Manipal Health Enterprises Ltd | (INE459N01021) | Healthcare Services | 1.15% | |
| Pfizer Limited | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.14% | |
| Aarti Pharmalabs Limited | AARTIPHARM (INE0LRU01027) | Pharmaceuticals & Biotechnology | 1.10% | |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.01% | |
| Kovai Medical Center and Hospital Limited | KOVAI (INE177F01017) | Healthcare Services | 0.99% | |
| Molbio Diagnostics Limited | (INE869T01028) | Healthcare Equipment & Supplies | 0.98% | |
| Aether Industries Limited | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 0.97% | |
| Jupiter Life Line Hospitals Limited | (INE682M01020) | Healthcare Services | 0.87% | |
| Senores Pharmaceuticals Limited | SENORES (INE0RB801010) | Pharmaceuticals & Biotechnology | 0.85% | |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.85% | |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.76% | |
| Vimta Labs Limited | VIMTALABS (INE579C01029) | Healthcare Services | 0.73% | |
| Nephrocare Health Services Ltd | NEPHROPLUS (INE428V01029) | Healthcare Services | 0.61% | |
| Innova Captab Limited | INNOVACAP (INE0DUT01020) | Pharmaceuticals & Biotechnology | 0.61% | |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.60% | |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.48% | |
| Sudeep Pharma Limited | SUDEEPPHRM (INE0QPI01025) | Chemicals & Petrochemicals | 0.47% | |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.41% | |
| Tatva Chintan Pharma Chem Limited | TATVA (INE0GK401011) | Chemicals & Petrochemicals | 0.39% | |
| Zota Health Care Limited | ZOTA (INE358U01012) | Pharmaceuticals & Biotechnology | 0.34% | |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 0.24% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.21% | |
| Bharat Parenterals Limited | (INE365Y01019) | Pharmaceuticals & Biotechnology | 0.04% |
Debt
| Name | Isin | Rating | Weight % | Yield |
|---|---|---|---|---|
| 91 Days Tbill (MD 05/11/2026) | IN002026X180 | Sovereign | 0.61% | 5.25% |
| 182 Days Tbill (MD 05/11/2026) | IN002026Y055 | Sovereign | 0.48% | 5.25% |
| 91 Days Tbill (MD 29/10/2026) | IN002026X172 | Sovereign | 0.37% | 5.14% |
| 91 Days Tbill (MD 03/09/2026) | IN002026X099 | Sovereign | 0.33% | 5.20% |
| 91 Days Tbill (MD 19/11/2026) | IN002026X206 | Sovereign | 0.33% | 5.26% |
| 91 Days Tbill (MD 22/10/2026) | IN002026X164 | Sovereign | 0.18% | 5.10% |
| 91 Days Tbill (MD 10/09/2026) | IN002026X107 | Sovereign | 0.13% | 5.18% |
| 182 Days Tbill (MD 12/11/2026) | IN002026Y063 | Sovereign | 0.08% | 5.25% |
| 364 Days Tbill (MD 12/11/2026) | IN002025Z336 | Sovereign | 0.01% | 5.25% |
Portfolio data is as on date 31 August, 2026
NAV history
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 October, 2026 | 17.220 | -0.36% |
| 30 September, 2026 | 17.282 | -1.81% |
| 29 September, 2026 | 17.601 | 0.11% |
| 28 September, 2026 | 17.582 | -1.31% |
| 25 September, 2026 | 17.815 | -0.11% |
| 24 September, 2026 | 17.835 | -0.76% |
| 23 September, 2026 | 17.971 | 1.01% |
| 22 September, 2026 | 17.791 | -0.64% |
| 21 September, 2026 | 17.906 | 0.65% |
| 18 September, 2026 | 17.790 | 1.02% |
| 17 September, 2026 | 17.611 | 1.28% |
| 16 September, 2026 | 17.388 | -0.41% |
| 15 September, 2026 | 17.460 | -1.67% |
| 11 September, 2026 | 17.756 | -0.45% |
| 10 September, 2026 | 17.837 | -0.05% |
| 9 September, 2026 | 17.846 | -0.01% |
| 8 September, 2026 | 17.847 | 0.97% |
| 7 September, 2026 | 17.675 | 0.72% |
| 4 September, 2026 | 17.549 | -0.65% |
| 3 September, 2026 | 17.663 | 0.1% |
| 2 September, 2026 | 17.646 | -0.12% |
| 1 September, 2026 | 17.667 | -0.9% |
| 31 August, 2026 | 17.827 | 0.45% |
| 28 August, 2026 | 17.747 | 0.21% |
| 27 August, 2026 | 17.709 | 0.49% |
| 26 August, 2026 | 17.623 | 0.32% |
| 25 August, 2026 | 17.566 | 0.69% |
| 24 August, 2026 | 17.446 | -0.06% |
| 21 August, 2026 | 17.456 | -0.37% |
| 20 August, 2026 | 17.520 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 17.220 as on 1 October, 2026.What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 21.19% as on 1 October, 2026.What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 22.13% as on 1 October, 2026.What are top 10 holdings of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
Top 10 holdings of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are:- Divi's Laboratories Limited
- Sun Pharmaceutical Industries Limited
- Torrent Pharmaceuticals Limited
- Apollo Hospitals Enterprise Limited
- Laurus Labs Limited
- Sai Life Sciences Limited
- Cipla Limited
- Max Healthcare Institute Limited
- Neuland Laboratories Limited
- IPCA Laboratories Limited
- Zydus Lifesciences Limited
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.